Cargando…

A Specific HPLC Method to Determine Residual HEPES in [(68)Ga]Ga-Radiopharmaceuticals: Development and Validation

Background: Nowadays, in Nuclear Medicine, clinically applied radiopharmaceuticals must meet quality release criteria such as high radiochemical purity and radiochemical yield. Many radiopharmaceuticals do not have marketing authorization and have no dedicated monograph within European Pharmacopeia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Migliari, Silvia, Scarlattei, Maura, Baldari, Giorgio, Silva, Claudia, Ruffini, Livia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323806/ https://www.ncbi.nlm.nih.gov/pubmed/35889351 http://dx.doi.org/10.3390/molecules27144477

Ejemplares similares

Validation of the HPLC Analytical Method for the Determination of Chemical and Radiochemical Purity of Ga-68-DOTATATE
por: Sammartano, Antonino, et al.
Publicado: (2023)

Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
por: Migliari, Silvia, et al.
Publicado: (2023)

Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [(68)Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method
por: Migliari, Silvia, et al.
Publicado: (2022)

Synthesis, validation and quality controls of [(68)Ga]-DOTA-Pentixafor for PET imaging of chemokine receptor CXCR4 expression
por: Sammartano, Antonino, et al.
Publicado: (2020)

New sensitive method for HEPES quantification in (68)Ga-radiopharmaceuticals
por: Antunes, I. F., et al.
Publicado: (2020)

Validation of Quality Control Parameters of Cassette-Based Gallium-68-DOTA-Tyr3-Octreotate Synthesis
por: Sammartano, Antonino, et al.
Publicado: (2020)

Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [(68)Ga]-Labeled Glu-Urea-Lys(Ahx)-HBED-CC (Positron Emission Tomography) Tracer
por: Migliari, Silvia, et al.
Publicado: (2017)

High Prognostic Value of (68)Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry
por: Gasparro, Donatello, et al.
Publicado: (2023)

Validation of in vitro labeling method for human use of heat-damage red blood cells to detect splenic tissue and hemocateretic function
por: Sammartano, Antonino, et al.
Publicado: (2019)

Development and evaluation of a rapid analysis for HEPES determination in (68)Ga-radiotracers
por: Pfaff, Sarah, et al.
Publicado: (2018)

Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

Good practices for (68)Ga radiopharmaceutical production
por: Nelson, Bryce J. B., et al.
Publicado: (2022)

[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021)

(68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
por: Velikyan, Irina
Publicado: (2015)

Cold Kit Labeling: The Future of (68)Ga Radiopharmaceuticals?
por: Lepareur, Nicolas
Publicado: (2022)

The use of HEPES-buffer in the production of gallium-68 radiopharmaceuticals – time to reconsider strict pharmacopoeial limits?
por: le Roux, Jannie, et al.
Publicado: (2021)

Instant kit preparation of (68)Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [(68)Ga]Ga-DATA-TOC
por: Sinnes, Jean-Philippe, et al.
Publicado: (2019)

Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals
por: Chi, Yen-Ting, et al.
Publicado: (2014)

Good practices for Ga-68 radiopharmaceutical production: an important correction
por: Gültekin, Aziz
Publicado: (2023)

Corrigendum to “Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals”
por: Chi, Yen-Ting, et al.
Publicado: (2016)

Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018)

SPECT/CT with (99m)Tc labelled heat-denatured erythrocyte to detect thoracic and abdominal splenic tissue
por: Graziani, Tiziano, et al.
Publicado: (2020)

Novel approach for quality assessment and improving diagnostic accuracy in cell-based infection imaging using (99)mTc-HMPAO labeled leukocytes
por: Silvia, Migliari, et al.
Publicado: (2018)

Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer
por: Scarlattei, Maura, et al.
Publicado: (2020)

Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the (68)Zn(p,n)(68)Ga Reaction and Their Regulatory Aspects
por: Ashhar, Zarif, et al.
Publicado: (2022)

A first-in-human study of [(68)Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
por: Ho Shon, Ivan, et al.
Publicado: (2022)

Novel Preclinical and Radiopharmaceutical Aspects of [(68)Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
por: Eder, Matthias, et al.
Publicado: (2014)

Cyclotron-based production of (68)Ga, [(68)Ga]GaCl(3), and [(68)Ga]Ga-PSMA-11 from a liquid target
por: Rodnick, Melissa E., et al.
Publicado: (2020)

Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
por: Petrik, Milos, et al.
Publicado: (2012)

Synthesis, Complexation Properties, and Evaluation of New Aminodiphosphonic Acids as Vector Molecules for (68)Ga Radiopharmaceuticals
por: Maruk, Alesya Ya., et al.
Publicado: (2021)

Automated GMP Production and Preclinical Evaluation of [(68)Ga]Ga-TEoS-DAZA and [(68)Ga]Ga-TMoS-DAZA
por: Greiser, Julia, et al.
Publicado: (2022)

Meningiomas: A Comparative Study of (68)Ga-DOTATOC, (68)Ga-DOTANOC and (68)Ga-DOTATATE for Molecular Imaging in Mice
por: Soto-Montenegro, María Luisa, et al.
Publicado: (2014)

N-Benzylethanolammonium Ionic Liquids and Molten Salts in the Synthesis of (68)Ga- and Al(18)F-Labeled Radiopharmaceuticals
por: Kondratenko, Yulia A., et al.
Publicado: (2023)

[(68)Ga]Ga-PSMA and [(68)Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration
por: Ghezzo, Samuele, et al.
Publicado: (2023)

An Overview of In Vitro Assays of (64)Cu-, (68)Ga-, (125)I-, and (99m)Tc-Labelled Radiopharmaceuticals Using Radiometric Counters in the Era of Radiotheranostics
por: Benfante, Viviana, et al.
Publicado: (2023)

Validation of HPLC method for the determination of chemical andradiochemical purity of a (68)Ga-labelled EuK-Sub-kf-(3-iodo-y-) DOTAGA
por: UĞUR, Ayşe, et al.
Publicado: (2021)

Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)

A prospective head-to-head comparison of [(68)Ga]Ga-P16-093 and [(68)Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
por: Wang, Guochang, et al.
Publicado: (2023)

The Role of [(68)Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
por: Albano, Domenico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_330tcudfljb5hhus2mm0fl09ha